quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·53d
PRRelease
Allurion Technologies Inc. logo

Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE

ALUR· Allurion Technologies Inc.
Health Care
Original source

Companies

  • ALUR
    Allurion Technologies Inc.
    Health Care

Recent analyst ratings

  • Nov 14UpdateChardan Capital Markets-
  • Oct 2UpdateTD Cowen$2.00
  • Sep 6UpdateROTH MKM$2.00
  • Feb 9UpdateJefferies$5.00

Related

  • SEC25d
    SEC Form 10-K filed by Allurion Technologies Inc.
  • SEC42d
    Allurion Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits
  • SEC52d
    Amendment: SEC Form SCHEDULE 13D/A filed by Allurion Technologies Inc.
  • SEC53d
    SEC Form 8-K filed by Allurion Technologies Inc.
  • SEC58d
    Allurion Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits
  • PR59d
    Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds
  • SEC60d
    Allurion Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR60d
    Allurion Receives U.S. FDA Approval
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022